The premorbid personality of patients with Parkinsons disease.- Parkinsons disease: development of dementia in aging.- Psychometric assessment of early signs of dementia in special consideration of Parkinsons and Alzheimers disease an update.- Sensory and musculo-skeletal dysfunction in Parkinsons diseasepremonitory and permanent.- Autonomic nervous system screening in patients with early Parkinsons disease.- Clinical and biochemical characteristics of early depression in Parkinsons disease.- Psychomotor investigations in depressed patients by comparison with Parkinson patients.- Quantitative analysis of voluntary and involuntary motor phenomena in Parkinsons disease.- Motor performance test.- Measuring body movements in neurological disease, with special reference to Parkinsons disease.- Long-term measurement of tremor: early diagnostic possibilities.- Tremor and electrically elicited long-latency reflexes in early stages of Parkinsons disease.- Evoked potentials in Parkinsons disease.- Brain mapping of EEG and evoked potentials during physiological aging and in Parkinsons disease, dementia and depression.- Positron emission tomography in Parkinsons disease glucose metabolism.- Parkinsons disease studied using PET.- Pathobiochemistry of the extrapyramidal system: a short note review.- Dopaminergic neurotransmission and status of brain iron.- Dopaminergic modulation of neuropeptide gene expression in the rat striatum.- The diagnostic relevance of Lewy bodies and other inclusions in Parkinsons disease.- Cytoskeletal pathology of the Lewy bodies.- Plasma concentrations of endogenous DOPA and 3-O-methyl-DOPA in rats administered benserazide and carbidopa alone or in combination with the reversible COMT inhibitor Ro41-0960.- Catecholamines in urine, blood and cerebrospinal fluid.- 3H-spiperone binding to lymphocytes is increased in schizophrenic patients and decreased in parkinson patients.- Platelet MAO-B activity in humans and stumptail monkeys: inlÂ